{ "cik": 1396814, "cik_padded": "0001396814", "entityName": "Pacira BioSciences, Inc.", "fiscal_years": [ { "accn": "0001628280-26-012297", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 148328000.0, "capex": 15333000.0, "cash": 158545000.0, "eps_diluted": 0.16, "free_cash_flow": 136661000.0, "net_income": 7034000.0, "operating_cash_flow": 151994000.0, "operating_income": 19191000.0, "revenue": 726411000.0, "stockholders_equity": 693111000.0, "total_assets": 1264917000.0, "total_liabilities": 571806000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8249847427035496, "net_margin": 0.009683223409337138, "operating_margin": 0.02641892812746503, "revenue_growth_yoy": 0.03629990612954123, "roa_avg2y": 0.004991426086765234, "roa_period_end": 0.0055608391696846515, "roe_avg2y": 0.00956057898996846, "roe_period_end": 0.010148446641302765 } }, { "accn": "0001628280-26-012297", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 25000000.0, "capex": 10636000.0, "cash": 276774000.0, "eps_diluted": -2.15, "free_cash_flow": 178753000.0, "net_income": -99560000.0, "operating_cash_flow": 189389000.0, "operating_income": -73371000.0, "revenue": 700966000.0, "stockholders_equity": 778348000.0, "total_assets": 1553516000.0, "total_liabilities": 775168000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9959144238823765, "net_margin": -0.1420325664868196, "operating_margin": -0.10467126793596265, "revenue_growth_yoy": 0.03850199562059801, "roa_avg2y": -0.06365928344302348, "roa_period_end": -0.06408688420331686, "roe_avg2y": -0.12079020769461285, "roe_period_end": -0.12791193656307975 } }, { "accn": "0001628280-26-012297", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 15161000.0, "cash": 153298000.0, "eps_diluted": 0.89, "free_cash_flow": 139488000.0, "net_income": 41955000.0, "operating_cash_flow": 154649000.0, "operating_income": 87675000.0, "revenue": 674978000.0, "stockholders_equity": 870130000.0, "total_assets": 1574386000.0, "total_liabilities": 704256000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8093687150195947, "net_margin": 0.06215758143228371, "operating_margin": 0.12989312244250925, "revenue_growth_yoy": 0.012229632151260529, "roa_avg2y": 0.02577416170237862, "roa_period_end": 0.026648483916904754, "roe_avg2y": 0.051004777708888, "roe_period_end": 0.048216933101950285 } }, { "accn": "0001628280-26-012297", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 30076000.0, "cash": 104139000.0, "eps_diluted": 0.34, "free_cash_flow": 115198000.0, "net_income": 15909000.0, "operating_cash_flow": 145274000.0, "operating_income": 60024000.0, "revenue": 666823000.0, "stockholders_equity": 775010000.0, "total_assets": 1681200000.0, "total_liabilities": 906190000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1692623320989406, "net_margin": 0.023857905321202178, "operating_margin": 0.09001489150794137, "revenue_growth_yoy": 0.23136170833541078, "roa_avg2y": 0.00846999895915218, "roa_period_end": 0.009462883654532477, "roe_avg2y": 0.021135658003292108, "roe_period_end": 0.02052747706481207 } }, { "accn": "0001396814-25-000041", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 45866000.0, "cash": 585578000.0, "eps_diluted": 0.92, "free_cash_flow": 79851000.0, "net_income": 41980000.0, "operating_cash_flow": 125717000.0, "operating_income": 89924000.0, "revenue": 541533000.0, "stockholders_equity": 730408000.0, "total_assets": 2075353000.0, "total_liabilities": 1344945000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.8413612665797745, "net_margin": 0.07752066817719326, "operating_margin": 0.16605451560662046, "revenue_growth_yoy": 0.2604137815462461, "roa_avg2y": 0.025063689114728768, "roa_period_end": 0.020227884123809298, "roe_avg2y": 0.062188170322702976, "roe_period_end": 0.057474726454255706 } }, { "accn": "0001396814-24-000030", "filed": "2024-02-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 37801000.0, "cash": 99957000.0, "eps_diluted": 3.33, "free_cash_flow": 39231000.0, "net_income": 145523000.0, "operating_cash_flow": 77032000.0, "operating_income": 46350000.0, "revenue": 429647000.0, "stockholders_equity": 619688000.0, "total_assets": 1274513000.0, "total_liabilities": 654825000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0567011141090354, "net_margin": 0.33870363344792354, "operating_margin": 0.10787925901961377, "revenue_growth_yoy": 0.025591631934995678, "roa_avg2y": 0.13822617827503897, "roa_period_end": 0.11417929828883659, "roe_avg2y": 0.298621428395538, "roe_period_end": 0.2348326899988381 } }, { "accn": "0001396814-23-000010", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 10159000.0, "cash": 78228000.0, "eps_diluted": -0.27, "free_cash_flow": 60361000.0, "net_income": -11016000.0, "operating_cash_flow": 70520000.0, "operating_income": 10480000.0, "revenue": 418926000.0, "stockholders_equity": 354944000.0, "total_assets": 831065000.0, "total_liabilities": 476121000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.341397516227912, "net_margin": -0.026295813580441415, "operating_margin": 0.025016351336512893, "revenue_growth_yoy": 0.26020449602469115, "roa_avg2y": -0.014490751885336795, "roa_period_end": -0.013255280874540499, "roe_avg2y": -0.032583521895381336, "roe_period_end": -0.03103588171655247 } }, { "accn": "0001396814-22-000021", "filed": "2022-02-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 14514000.0, "cash": 132526000.0, "eps_diluted": -0.01, "free_cash_flow": 34356000.0, "net_income": -471000.0, "operating_cash_flow": 48870000.0, "operating_income": 15915000.0, "revenue": 332427000.0, "stockholders_equity": 321226000.0, "total_assets": 689353000.0, "total_liabilities": 368127000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.14600623859837, "net_margin": -0.0014168524217346963, "operating_margin": 0.04787517259428386, "revenue_growth_yoy": 0.1691097340526549, "roa_avg2y": -0.0007148689710440122, "roa_period_end": -0.0006832493657095858, "roe_avg2y": -0.0015681469729935792, "roe_period_end": -0.00146625740133115 } }, { "accn": "0001396814-21-000014", "filed": "2021-03-01", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 19266000.0, "cash": 54126000.0, "eps_diluted": -1.07, "free_cash_flow": -1481000.0, "net_income": -42611000.0, "operating_cash_flow": 17785000.0, "operating_income": -24937000.0, "revenue": 284342000.0, "stockholders_equity": 279483000.0, "total_assets": 628371000.0, "total_liabilities": 348888000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.248333530125267, "net_margin": -0.1498582692672908, "operating_margin": -0.08770072658981086, "revenue_growth_yoy": 0.05283386343692261, "roa_avg2y": -0.08356433430048135, "roa_period_end": -0.06781185000580867, "roe_avg2y": -0.170970932413699, "roe_period_end": -0.15246365610788493 } }, { "accn": "0001396814-20-000008", "filed": "2020-02-21", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 24709000.0, "cash": 35944000.0, "eps_diluted": -1.02, "net_income": -37949000.0, "operating_income": -32024000.0, "revenue": 270073000.0, "stockholders_equity": 218976000.0, "total_assets": 391466000.0, "total_liabilities": 172490000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7877118953675288, "net_margin": -0.14051386106719294, "operating_margin": -0.11857534814661222, "roa_period_end": -0.09694073048489522, "roe_period_end": -0.17330209703346486 } }, { "accn": "0001047469-13-002336", "filed": "2013-03-07", "fiscal_year": 2010, "form": "10-K", "fundamental_units": { "buybacks": "USD" }, "fundamentals": { "buybacks": 2000.0 }, "period_end": "2010-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-012297", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001396814.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001396814.json" }, "ticker": "PCRX" }